InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by WEISNER AIMEE S, Director. Insider active across 4 companies, notably GLAUKOS Corp. Aggregated, 11 reports have been logged. The latest transaction was filed on 6 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
03,573 shares0
Common Stock
SEC:0001209191-22-035063:0·
04,364 shares0
Common Stock
SEC:0001104659-22-068669:0·
04,285 shares0
Common Stock
SEC:0000899243-22-020017:0·
01,455 shares0
Common Stock
SEC:0001104659-22-001665·
01,455 shares0
Common Stock
SEC:0001104659-22-001665:0·
€88,0182,000 shares@ €44.00920.0014% mcap100.0% of flow
Common Stock
SEC:0001104659-21-102397·
€88,0182,000 shares@ €44.00920.0014% mcap50.0% of flow
Common Stock
SEC:0001104659-21-102397:0·
03,466 shares0
Common Stock
SEC:0001209191-21-039342·
03,466 shares0
Common Stock
SEC:0001209191-21-039342:0·
02,382 shares0
Common Stock
SEC:0001104659-21-077836·
02,382 shares0
Common Stock
SEC:0001104659-21-077836:0·
11 of 11 declarations
About WEISNER AIMEE S
Aimee S. Weisner serves as a board member at GLAUKOS Corp and Oyster Point Pharma, Inc. She plays a vital role in overseeing operations and making strategic decisions for these companies. Her expertise in biopharmaceuticals is crucial for ensuring the growth and sustainability of GLAUKOS and Oyster Point.
